Replies to post #338069 on Amarin Corp Plc (AMRN)

[shadolane]

AMRN is swimming upstream in the US it seems. If the generics are allowed to infringe without limit which could happen what's the point?

Seems like from a purely business perspective focusing on other markets makes sense.